Originally developed for type 2 diabetes, GLP-1 receptor agonists are now driving one of the fastest-growing pharmaceutical markets globally - with expanding applications in obesity management, cardiovascular health, and other chronic conditions
392: s325 DOI: 10.1136/bmj.s325 Cite This Page : ScienceDaily
How do they affect gut health
Injectable GLP-1s have been studied in large human trials with clear dosing, safety monitoring, and proven effects on appetite and weightevidence that patches currently lack
Wang C, Li Q, Wang W, Guo L, Guo C, Sun Y, et al
Its a type of sugar that plays a crucial role in your bodys cell membranes